-
FDA Introduces A New Web Site Intended To Give The Public More Insight About Agency’s Work
FDA Basics: Site Seeks To Present Information To Consumers And Patients In Useful And User-Friendly Format (Posted by Tom Lamb at DrugInjuryWatch.com) On January 12, 2009 Dr. Joshua Sharfstein, Principal Deputy Commissioner of the…
-
GE Healthcare Seemingly Tries To Intimidate And Silence A Critic Of Its Omniscan Product
Drug Company Files Libel Lawsuit In UK Against Prominent Danish Radiologist Henrik Thomsen (Posted by Tom Lamb at DrugInjuryWatch.com) The Sunday Times (UK) recently ran a story that demonstrates how Britain's libel laws are possibly…
-
FDA Wants Studies Done On Byetta Safety, With Focus On Pancreatitis, Pancreatic Cancer, Thyroid Neoplasm, And Acute Renal Failure
FDA Letter About Byetta Sent To Amilyn In October 2009; Drug Company Tries To Downplay, But Investors React When They Learn About It In December 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) On October…
-
Levaquin Has Been Associated With Dysglycemia Events Such As Hyperglycemia And Hypoglycemia
North Carolina Case Report: Man With Diabetes Develops Low Blood Sugar After Using Levaquin Together With Glucotrol (Posted by Tom Lamb at DrugInjuryWatch.com) Three years ago to the day we posted an article, back in…
-
Sprint Fidelis Lead Wire Failure Rate Could Rise To 30 Percent By Four Years
About 260,000 Medtronic Sprint Fidelis Leads Were Implanted In US, With Approximately 143,000 Still Active (Posted by Tom Lamb at DrugInjuryWatch.com) The December 28, 2009 edition of "US Morning Meeting Highlights" from UBS Investment…
-
A New Year’s Resolution For The FDA, As Recommended By The GAO
FDA Needs To Restructure Its Staff In Order To Better Monitor Emerging Drug Safety Issues (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-December 2009 the Government Accounting Agency (GAO) — often referred to as…
